CY1114258T1 - BETA HYDROSUMPHONE AND PRODUCERS FOR DEPARTMENT AND ANXIETY TREATMENT - Google Patents

BETA HYDROSUMPHONE AND PRODUCERS FOR DEPARTMENT AND ANXIETY TREATMENT

Info

Publication number
CY1114258T1
CY1114258T1 CY20131100424T CY131100424T CY1114258T1 CY 1114258 T1 CY1114258 T1 CY 1114258T1 CY 20131100424 T CY20131100424 T CY 20131100424T CY 131100424 T CY131100424 T CY 131100424T CY 1114258 T1 CY1114258 T1 CY 1114258T1
Authority
CY
Cyprus
Prior art keywords
subject
hydrosumphone
producers
beta
department
Prior art date
Application number
CY20131100424T
Other languages
Greek (el)
Inventor
David Greenwood
Wilfried Dimpfel
Original Assignee
Btg International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0420856A external-priority patent/GB0420856D0/en
Application filed by Btg International Limited filed Critical Btg International Limited
Publication of CY1114258T1 publication Critical patent/CY1114258T1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Παρέχεται μια μέθοδος για τη θεραπεία ενός υποκειμένου που έχει ανάγκη θεραπείας για κατάθλιψη, άγχος, εξασθενημένη γνωστική λειτουργία ή/και πόνο, που περιλαμβάνει χορήγηση στο εν λόγω υποκείμενο μιας ποσότητας ενός κετογονικού υλικού αρκετού για να δώσει μια κέτωση στο υποκείμενο αρκετή για να παρέχει αντικαταθλιπτικό αποτέλεσμα, ενισχυτικό της γνωστικής λειτουργίας ή/και αναλγητικό αποτέλεσμα. Προτιμώμενα υλικά παράγουν κέτωση κατά το ότι η ολική συγκέντρωση ακετοοξεικού και (R)-3-υδροξυβουτυρικού στο αίμα του υποκειμένου αυξάνεται μεταξύ 0,1 και 30mM.A method is provided for treating a subject in need of treatment for depression, anxiety, impaired cognitive function and / or pain, comprising administering to said subject a quantity of ketogenic material sufficient to give a subject sufficient to provide antidepressant. effect, cognitive enhancement and / or analgesic effect. Preferred materials produce ketosis in that the total concentration of acetoacetate and (R) -3-hydroxybutyrate in the subject's blood increases between 0.1 and 30 mM.

CY20131100424T 2004-05-12 2013-05-29 BETA HYDROSUMPHONE AND PRODUCERS FOR DEPARTMENT AND ANXIETY TREATMENT CY1114258T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57013704A 2004-05-12 2004-05-12
GB0420856A GB0420856D0 (en) 2004-09-20 2004-09-20 Cns modulators
EP05742109.1A EP1755743B1 (en) 2004-05-12 2005-05-12 Beta hydroxybutyrate and derivatives for treating depression and anxiety

Publications (1)

Publication Number Publication Date
CY1114258T1 true CY1114258T1 (en) 2016-08-31

Family

ID=58436472

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100424T CY1114258T1 (en) 2004-05-12 2013-05-29 BETA HYDROSUMPHONE AND PRODUCERS FOR DEPARTMENT AND ANXIETY TREATMENT

Country Status (1)

Country Link
CY (1) CY1114258T1 (en)

Similar Documents

Publication Publication Date Title
CY1118529T1 (en) GLATIRAMER ACETATE LOW FREQUENCY TREATMENT
CY1111153T1 (en) FORM OF OSMOTIC DOSAGE OF PERSONAL LIFE
CY1108436T1 (en) ADMINISTRATION OF KASAKINOIDS
CY1110133T1 (en) HYPERPLOYEES THERAPEUTIC THERAPY INCLUDING PITAVASTATINES AND VISCENTAGENIC ACID
DE60109589D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN, CHRONIC PAIN AND / OR NEUROPATHIC PAIN AND MIGRAINE
PT1143937E (en) THE EFFECTIVE DECLINE OF EFFECTIVE DRUG CONCENTRATIONS IN THE PLASMA CONTROLLED FREQUENCY FORMULATIONS WITH A RAPID START
FR2869231B1 (en) THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
CY1112738T1 (en) A COMBINED COMPOSITION CONTAINING Ibuprofen And Paracetamol
CY1111812T1 (en) HUMAN DEFENDANT ANTI-IFN-C ANTIBODIES AS EFFECTS OF IFN-C PATH
NO20034684L (en) Coating microprojection device containing an advantageous agent
CY1110783T1 (en) Monoclonal Antibodies Against Growth Factor
CY1105501T1 (en) DRUG COMBINATIONS (EG CHLORPROMAZINE AND PENTAMIDINE) FOR THE TREATMENT OF NEOPLASTIC DISORDERS
DE59508360D1 (en) LIPOSOMAL-ENCLOSED TAXOL, ITS PRODUCTION AND USE
CY1118924T1 (en) METHOD FOR THE TREATMENT OF FIRST AUTOPATH
DE60230869D1 (en) 4- (PHENYLPIPERAZINYLMETHYL) BENZAMID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PAIN, FEAR OR GASTROINTESTINAL DISORDER
DE50006156D1 (en) DEVICE AND USE FOR INCREASING THE TRANSDERMAL PERMEATION OF MEDICAMENTS
ATE513562T1 (en) NON-SPECIFIC IMMUNO-STIMULANT AGENTS
CY1113116T1 (en) Substituted 4-Aminocyclohexanols
PT1173201E (en) METHOD FOR THE TREATMENT OF FIBROSIS USING AN ALTAGONIST OF THE ALPHA 4 SUBSTANCE OF INTEGRINA
CY1115407T1 (en) THORIO-227 FOR USE IN SOFT TISSUE RADIATION
ATE516366T1 (en) REGULATED APTAMER THERAPEUTICS
DE60205894D1 (en) 4- (PHENYL-PIPERIDIN-4-YLIDENETHYL) -BENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PAIN, ANXIETY OR GASTROINTESTINAL DISORDER
DK1843757T3 (en) Treatment of Phantom Phenomena
CY1114258T1 (en) BETA HYDROSUMPHONE AND PRODUCERS FOR DEPARTMENT AND ANXIETY TREATMENT